AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Impact of FDA Cuts on Device Department
This chapter discusses the recent cuts made by the FDA and their disproportionate impact on the device department compared to biotech. It highlights concerns over staffing shortages, delays in drug manufacturing inspections, and the potential implications for pharmaceutical companies and device reviews.